Odyssey Therapeutics, Inc
Price
FilingsNewest: 8-K, Regulation FD disclosureSep 8 →Insiders10 insiders bought $75.3M in 9 open-market buys. 2 insiders sold $32,040, 0 of 3 sales on a 10b5-1 plan.→HoldersFMR 10.8%SR One 7.9%TPG GP A 7.7%→Financing →
From the filings
Figures
- Cash and equivalents
- $82.0Mat the last balance sheet
- Shares outstanding
- 47.9M shareson issue